Andrea(Flynn)FransonMDMS(She/Her)

Pediatric Hematology & Oncology • Ann Arbor, MI

Program Director, Pediatric Hematology/Oncology Fellowship

Join to view full profile

Dr. Franson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Franson's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Summary

Dr. Andrea Franson is a pediatric hematologist/oncologist in Ann Arbor, MI and is affiliated with Michigan Medicine. She received her medical degree from University of Michigan Medical School and did pediatric and pediatric hematology/oncology training at the Children's Hospital of Philadelphia. She is experienced in neuro-oncology and early-phase clinical trials.

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2014 - 2017
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2011 - 2014
University of Michigan Medical SchoolClass of 2011

Certifications & Licensure

MI State Medical License 2019 - 2026
PA State Medical License 2011 - 2021
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial Start of enrollment: 2021 May 03
Active, not recruiting
Phase 2
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors Start of enrollment: 2021 Aug 23
Recruiting
Phase 1
Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation Start of enrollment: 2020 Sep 18
Completed
Not Applicable
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
Active, not recruiting
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.
Nir Erez, Noa Furth, Vadim Fedyuk, Jack Wadden, Rayan Aittaleb
Cell Reports. Medicine. 2025-01-21
Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.
Holly J Roberts, Karthik Ravi, Bernard L Marini, Allison Schepers, Cassie Kline
Journal of Pediatric Hematology/oncology. 2025-01-01
Germline loss-of-function variant in the E3 ubiquitin ligase TRAF2 in a young adult patient with medulloblastoma: a case report.
Josh N Vo, Andrea Franson, Sebastian M Waszak, Yi-Mi Wu, Nicole Becker
Acta Neuropathologica Communications. 2024-12-20

Press Mentions

A Novel ATXN1-DUX4 Fusion Expands the Spectrum of ‘CIC-Rearranged Sarcoma’ of the CNS to Include Non-CIC AlterationsFebruary 7th, 2021